Cargando…
Chir99021 and Valproic acid reduce the proliferative advantage of Apc mutant cells
More than 90% of colorectal cancers carry mutations in Apc that drive tumourigenesis. A 'just-right' signalling model proposes that Apc mutations stimulate optimal, but not excessive Wnt signalling, resulting in a growth advantage of Apc mutant over wild-type cells. Reversal of this growth...
Autores principales: | Langlands, Alistair J., Carroll, Thomas D., Chen, Yu, Näthke, Inke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833359/ https://www.ncbi.nlm.nih.gov/pubmed/29449562 http://dx.doi.org/10.1038/s41419-017-0199-9 |
Ejemplares similares
-
CHIR99021 Maintenance of the Cell Stemness by Regulating Cellular Iron Metabolism
por: Han, Yingying, et al.
Publicado: (2023) -
GSK-3 inhibitor CHIR99021 enriches glioma stem-like cells
por: Yang, Yang, et al.
Publicado: (2020) -
Identification of metabolic pathways underlying FGF1 and CHIR99021-mediated cardioprotection
por: Xu, Bing, et al.
Publicado: (2022) -
5-Aza-2′-Deoxycytidine and Valproic Acid in Combination with CHIR99021 and A83-01 Induce Pluripotency Genes Expression in Human Adult Somatic Cells
por: Aguirre-Vázquez, Alain, et al.
Publicado: (2021) -
CHIR99021 Augmented the Function of Late Endothelial Progenitor Cells by Preventing Replicative Senescence
por: Rethineswaran, Vinoth Kumar, et al.
Publicado: (2021)